Lunesta, Crestor, Sanctura Among New Products In UnitedHealth Registry
Executive Summary
Sepracor's insomnia agent Lunesta, AstraZeneca's statin Crestor and Indevus' overactive bladder therapy Sanctura are among the new products to be included in UnitedHealth's postmarketing surveillance drug registry